Nestle CEO says weight-loss drugs no threat to coffee business
Nestle sees no threat to its huge coffee business from the rising popularity of weight-loss drugs like Eli Lilly's Zepbound and Novo Nordisk's Wegovy, Chief Executive Mark Schneider said on Wednesday.